CA2154062C - Spectrophotometric examination of tissue of small dimension - Google Patents
Spectrophotometric examination of tissue of small dimension Download PDFInfo
- Publication number
- CA2154062C CA2154062C CA002154062A CA2154062A CA2154062C CA 2154062 C CA2154062 C CA 2154062C CA 002154062 A CA002154062 A CA 002154062A CA 2154062 A CA2154062 A CA 2154062A CA 2154062 C CA2154062 C CA 2154062C
- Authority
- CA
- Canada
- Prior art keywords
- optical
- radiation
- medium
- property
- spectrophotometric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000003287 optical effect Effects 0.000 claims abstract description 137
- 230000005855 radiation Effects 0.000 claims abstract description 46
- 238000001514 detection method Methods 0.000 claims abstract description 19
- 238000010521 absorption reaction Methods 0.000 claims description 28
- 108010054147 Hemoglobins Proteins 0.000 claims description 16
- 102000001554 Hemoglobins Human genes 0.000 claims description 16
- 238000002798 spectrophotometry method Methods 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 238000001574 biopsy Methods 0.000 claims description 4
- 230000005670 electromagnetic radiation Effects 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 238000001727 in vivo Methods 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 2
- 238000006213 oxygenation reaction Methods 0.000 claims 2
- 238000013508 migration Methods 0.000 abstract description 8
- 230000005012 migration Effects 0.000 abstract description 8
- 230000001766 physiological effect Effects 0.000 abstract description 5
- 238000005259 measurement Methods 0.000 description 14
- 230000010363 phase shift Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- 238000000926 separation method Methods 0.000 description 6
- 229940028435 intralipid Drugs 0.000 description 5
- 239000013307 optical fiber Substances 0.000 description 5
- 108010064719 Oxyhemoglobins Proteins 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 230000009977 dual effect Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 3
- 235000013405 beer Nutrition 0.000 description 3
- 230000008033 biological extinction Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000006229 carbon black Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 210000000624 ear auricle Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002496 oximetry Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- 229920006328 Styrofoam Polymers 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical group O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000008261 styrofoam Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14552—Details of sensors specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14553—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for cerebral tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
- G01N21/03—Cuvette constructions
- G01N2021/0342—Solid sample being immersed, e.g. equiindex fluid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N2021/1789—Time resolved
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/314—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
- G01N2021/3144—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths for oxymetry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4795—Scattering, i.e. diffuse reflection spatially resolved investigating of object in scattering medium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/069—Supply of sources
- G01N2201/0696—Pulsed
Abstract
A system (10) for examination of a volume of biological tissue using visible or infra-red radiation includes a spectrophotometer (18), an optical medium (12) having selectable scattering and absorptive properties, and a processor (35) for determining a physiological property of the examined tissue. The spectrophotometer (18) includes a light source (21) for introducing radiation at an optical input port (19) and a detector (23) for detecting radiation that has migrated through a path from the input port ( 19) to an optical detection port (21). The biological tissue is positioned into a photon migration path inside the optical medium (12) to create a tissue medium optical path. The optical medium (12) is adapted to limit substantially escape of photons from the tissue.
The processor (35) determines tissue properties based on the detected optical property of the tissue-medium optical path and the selectable properties of the optical medium (12).
The processor (35) determines tissue properties based on the detected optical property of the tissue-medium optical path and the selectable properties of the optical medium (12).
Description
2154x62 BP$CTROP80T01!t~3C B~~KINATiON
OF TIB80$ OF BIrIALL DID
The present invention is related to US Patent No.
5,119,815, issued June 9, 1992 and is also related to US
Patent application serial no. 645,590 filed January 24, 1991, published as WO 92/13598 (PCT/US92/00463) on 20 August 1992, and US Patent application serial no.
701,127 filed May 16, 1991 published as WO 92/20273 (PCT/US92/04153) on 26 November 1992.
15 Backaround o~ the Invention Continuous wave (CW) spectrophotometers have been widely used to determine in vivo concentration of an optically absorbing pigment (e. g., hemoglobin, oxyhemoglobin) in biological tissue. The CW
20 spectrophotometers, for example, in pulse oitimetry introduce light into a finger or the ear lobe to measure the light attenuation and then evaluate the concentration based on the Beer Lambent equation or modified Heer Lambent absorbance equation. The Beer Lambent equation ,. 25 (1) describes the relationship between the concentration ~~
of an absorbent constituent (C), the extinction coefficient (s), the photon migration pathlength <L>, and the attenuated light intensity (I/Io).
lOg (I~I~] -~ EiCi (1, <L>
However, direct application of the Beer Lambent equation 30 poses several problems. Since the tissue structure and physiology vary significantly, the optical pathlength of migrating photons also varies significantly and can not be simply determined from geometrical position of a 'A
WO 94/16615 p 21 ~ 4 0 6 ~
OF TIB80$ OF BIrIALL DID
The present invention is related to US Patent No.
5,119,815, issued June 9, 1992 and is also related to US
Patent application serial no. 645,590 filed January 24, 1991, published as WO 92/13598 (PCT/US92/00463) on 20 August 1992, and US Patent application serial no.
701,127 filed May 16, 1991 published as WO 92/20273 (PCT/US92/04153) on 26 November 1992.
15 Backaround o~ the Invention Continuous wave (CW) spectrophotometers have been widely used to determine in vivo concentration of an optically absorbing pigment (e. g., hemoglobin, oxyhemoglobin) in biological tissue. The CW
20 spectrophotometers, for example, in pulse oitimetry introduce light into a finger or the ear lobe to measure the light attenuation and then evaluate the concentration based on the Beer Lambent equation or modified Heer Lambent absorbance equation. The Beer Lambent equation ,. 25 (1) describes the relationship between the concentration ~~
of an absorbent constituent (C), the extinction coefficient (s), the photon migration pathlength <L>, and the attenuated light intensity (I/Io).
lOg (I~I~] -~ EiCi (1, <L>
However, direct application of the Beer Lambent equation 30 poses several problems. Since the tissue structure and physiology vary significantly, the optical pathlength of migrating photons also varies significantly and can not be simply determined from geometrical position of a 'A
WO 94/16615 p 21 ~ 4 0 6 ~
-2-source and detector. In addition, the photon migration pathlength itself is a function of the relative concentration of absorbing constituents. As a result, the pathlength through an organ with high blood hemoglobin concentration, for example, will be different from the same with a low blood hemoglobin concentration.
Furthermore, the pathlength is frequently dependent upon the wavelength of the light since the absorption coefficient of many tissue constituents is wavelength dependent. One solution to this problem is to determine s, C, and <L> at the same time, but this is not possible with the CW oximeters.
Furthermore, for quantitative measurement of tissue of a small volume (e. g., a finger) photon escape introduces a significant error since the photons escaped from the tissue are counted as absorbed.
There are several reasons for using in vivo tissue oximetry. Although the arterial oxygen saturation can be in vitro quantified, it is not possible to estimate the change in the hemoglobin oxygen concentration as it leaves an artery and enters the capillary bed. Neither is it possible to determine the intermediate value of oxygen saturation in a particular capillary bed from the venous drainage since no technique has been devised for drawing a blood sample directly from the capillary bed.
In the time resolved (TRS-pulse) and phase modulation (PMS) spectrophotometers that can measure the average pathlength of migrating photons directly, but the proper quantitation of the time resolved or frequency resolved spectra can be performed only when the spectra are collected at a relatively large source-detector separation. This separation is difficult to achieve for a small volume of tissue such as the earlobe, a finger or a biopsy tissue.
2~~~~~~
Furthermore, the pathlength is frequently dependent upon the wavelength of the light since the absorption coefficient of many tissue constituents is wavelength dependent. One solution to this problem is to determine s, C, and <L> at the same time, but this is not possible with the CW oximeters.
Furthermore, for quantitative measurement of tissue of a small volume (e. g., a finger) photon escape introduces a significant error since the photons escaped from the tissue are counted as absorbed.
There are several reasons for using in vivo tissue oximetry. Although the arterial oxygen saturation can be in vitro quantified, it is not possible to estimate the change in the hemoglobin oxygen concentration as it leaves an artery and enters the capillary bed. Neither is it possible to determine the intermediate value of oxygen saturation in a particular capillary bed from the venous drainage since no technique has been devised for drawing a blood sample directly from the capillary bed.
In the time resolved (TRS-pulse) and phase modulation (PMS) spectrophotometers that can measure the average pathlength of migrating photons directly, but the proper quantitation of the time resolved or frequency resolved spectra can be performed only when the spectra are collected at a relatively large source-detector separation. This separation is difficult to achieve for a small volume of tissue such as the earlobe, a finger or a biopsy tissue.
2~~~~~~
- 3 -Therefore, there is a need for a spectrophotometric system and method for quantitative examination of a relatively small volume of biological tissue.
Summary of the Invention The invention features a spectrophotometric system for examination of a relatively small volume of biological tissue of interest using visible or infra-red radiation.
According to one aspect of the invention, a spectrophotometric system for examination of a relatively small object of interest (e. g., biological tissue, organic or inorganic substance in a solid, liquid or gaseous state) using visible or infra-red radiation introduced to a path passing through the object. The system includes a spectrophotometer with an optical input port adapted to introduce radiation into the object and an optical detection port adapted to detect radiation that has migrated through a path in the object, photon escape preventing means arranged around the relatively small object of interest and adapted to limit escape of the introduced photons outside the object, and processing means adapted to determine an optical property of the object based on the changes between the introduced and the detected radiation.
According to another aspect of the invention, a system for examination of a relatively small volume of biological tissue of interest using visible or infra-red radiation includes a spectrophotometer with a light source adapted to introduce radiation at an optical input port, a detector adapted to detect radiation that has migrated through a path from the input port to an optical detection port, and a processor adapted to evaluate changes between the introduced and the detected
Summary of the Invention The invention features a spectrophotometric system for examination of a relatively small volume of biological tissue of interest using visible or infra-red radiation.
According to one aspect of the invention, a spectrophotometric system for examination of a relatively small object of interest (e. g., biological tissue, organic or inorganic substance in a solid, liquid or gaseous state) using visible or infra-red radiation introduced to a path passing through the object. The system includes a spectrophotometer with an optical input port adapted to introduce radiation into the object and an optical detection port adapted to detect radiation that has migrated through a path in the object, photon escape preventing means arranged around the relatively small object of interest and adapted to limit escape of the introduced photons outside the object, and processing means adapted to determine an optical property of the object based on the changes between the introduced and the detected radiation.
According to another aspect of the invention, a system for examination of a relatively small volume of biological tissue of interest using visible or infra-red radiation includes a spectrophotometer with a light source adapted to introduce radiation at an optical input port, a detector adapted to detect radiation that has migrated through a path from the input port to an optical detection port, and a processor adapted to evaluate changes between the introduced and the detected
- 4 -radiation. The system also includes an optical medium of a relatively large volume, forming photon preventing means, having selectable scattering and absorptive properties, positioning means adapted to locate the biological tissue of interest into the migration path to create a tissue-medium optical path, the optical medium substantially limiting escape of photons from the tissue-medium optical path, and processing means adapted to determine a physiological property of the tissue based on the detected optical property of the tissue-medium optical path and the scattering or absorptive properties of the optical medium.
Preferred embodiments of these aspects of the invention include one or more of the following features.
The photon escape preventing means include an optical medium of a selectable optical property surrounding the object. The selectable optical property is an absorption or scattering coefficient.
The photon escape preventing means include an optical medium surrounding the object; the medium has at least one opticzl property substantially matched to the optical property of the object.
The spectrophotometer is a continuous wave spectrophotometer, a phase modulation spectroscopic unit or time resolved spectroscopic unit.
The determined physiological property is the hemoglobin saturation, the concentration of an enzyme or the concentration of a tissue substance such as glucose.
The system performs a single measurement or a continuous, time-dependent monitoring of the selected physiological property.
The above-described system operates by introducing into the object, surrounded by the photon escape preventing means, electromagnetic radiation of a selected wavelength and detecting radiation that has migrated in ~~54os2
Preferred embodiments of these aspects of the invention include one or more of the following features.
The photon escape preventing means include an optical medium of a selectable optical property surrounding the object. The selectable optical property is an absorption or scattering coefficient.
The photon escape preventing means include an optical medium surrounding the object; the medium has at least one opticzl property substantially matched to the optical property of the object.
The spectrophotometer is a continuous wave spectrophotometer, a phase modulation spectroscopic unit or time resolved spectroscopic unit.
The determined physiological property is the hemoglobin saturation, the concentration of an enzyme or the concentration of a tissue substance such as glucose.
The system performs a single measurement or a continuous, time-dependent monitoring of the selected physiological property.
The above-described system operates by introducing into the object, surrounded by the photon escape preventing means, electromagnetic radiation of a selected wavelength and detecting radiation that has migrated in ~~54os2
- 5 -the Abject from the input port to the optical detection port. The system determines an optical property of the object based on the changes between the introduced and the detected radiation. In addition, different photon escape preventing means having a surrounding optical medium with the optical property comparable to the optical property of the object may be selected. Then, the system measures again the optical property of the object. The measurements may be repeated iteratively until the optical property of the surrounding medium is substantially matched to the optical property of the object.
In a further aspect, the invention provides a spectrophotometric method of examination of an object of interest using visible or infra-red radiation introduced to optical paths passing through the object, the method comprising the steps of:
(a) providing, at the object, optical means for limiting escape of photons or accounting for escaped photons from inside to outside of the object, (b) introducing into the object, at an optical input port, electromagnetic radiation of a selected wavelength in the visible or infra-red range, (c) detecting radiation that has migrated in the object from the input port to an optical detection port, and (d) determining an optical property of the object based on the changes between the introduced and the detected radiation.
A
In a further aspect, the invention provides a spectrophotometric method of examination of an object of interest using visible or infra-red radiation introduced to optical paths passing through the object, said method comprising the steps of:
(a) providing, at said objectr optical means for limiting escape of photons or providing retuzn paths for photons escaped from inside to outside of said object, (b} introducing into the object, at an optical input port, electromagnetic radiation of a wavelength in the visible or infra-xed range, photons of said radiation tnigxating inside of said object, (c} detecting photons of said radiation that has migrated in said object from said input port to an optical detection port, the detected radiation also including photons that returned from outside of sa~.d object into said object, and (d) determining an optical property of said object based'on the changes of properties of the introduced and the detected radiation.
In a further aspect, the invention pxovides a spectrophotometric system for examination of an object o~
interest using visible or infra-red radiation introduced to optzCal paths passing through the object, said system Comprising:
a spectrophotometer unit including a light source optically connected to an optical input port adapted to introduce photons of said radiation into the object, the introduced photons migrating inside of said object, and a light detector optically connected to an optical detection port adapted Co detect radiation that has migrated over optical paths in the object, optical means axranged at the object of interest and adapted to limit escape of the introduced photons or provide return paths far photons escaped from inside to outside of the object.
processing means, connected to said spectrophotometer unit, adapted to determine an optical property of the object based on the changes between the introduced and the detected radiation, the detected radiation also including photons that returned from outside of said object into said object.
Hrief Desarimtion o~ the cawing Fig. 1 is a diagrammatic view o! a spaatrophotometric system for examination of tissue of a relatively small dimension.
Figs. 2 and 2A show different views of a cylinder . for preventing escape of photons during speatrQphotometric measurements of a finger.
Fig. 2H shows a sat of ayliDderø of preselected optical properties far a finger oximetry.
Fig. 3 is a diagrammatic view of an optical fiber holder !or a spsctrophotometxia study of the head.
Fig. 4 is a diagramwdtic view of a TRS test system used for finger examiDat~op.
Pigs. 4A and 48 display measured values of the absorption coefficient seasured fn a test, and~Fig. 4C
displays their relative occurrence.
Figs. 4D and 4E display mgasured~values of the ' scattering coefficient and their relative occurrence respectiveiy.
Figs. 4P and 4G display calculated values of the hemoglobin saturation and their relative oaaurrenae, respectively.
wo 9mss~.s ,... ..., ~.rtJS9oioo~z w Referring to Fig. 1, ,a system 10 for examination of biological tissue of a relatively small volume, includes an optical medium 12 of selectable optical properties, a spectrophotometer 18, a titrimetric circulation system 30,. and computer control 35.
Biological tissue of interest 14, attached to a locator 15, is immersed in optical medium 12. Spectrophotometer 18 examines optical properties of medium 12 by employing visible or infra-red light conducted via light guides 20 and 22. Light guides 20 and 22, which in a preferred embodiment are optical fibers, are connected to alight source 18A and a light detector 23, respectively. Photons introduced at an optical input port 19 migrate in medium 12 through a scattering and absorptive path and are detected at a detection port 2l. The selectable fixed geometry of input port 19 and detection port 21 controls the migration path, i.e., optical field 25.
System 30 is adapted to change precisely the 2o scattering and absorptive properties of medium 12.
Medium 12 includes intralipid solution (made by Kabi Vitrum, Inc., Clapton, NC) that exhibits scattering properties depending on its concentration and carbon black India ink that exhibits absorptive properties. The scattering or absorptive properties of medium 12 can be either maintained constant and uniform by properly mixing the solution or can be changed almost continuously by changing the concentration of the constituents in titration system 30. Tubes 32 and 34 are adapted far continuous circulation of the solution.
In system operation, tissue 14 is first located away from optical field 25. Spectrophotometer 18 examines medium 12 in field region 25, and control 35 compares the detected data to the preselected values of the absorption coefficient (~.a) and the scattering WO 94/16615 _ ,~ PCT/US94/00732 coefficient (Ecs). Next, locator 15 positions tissue 14 into field 25 and spectrophotometer 18 measures the optical properties of tissue 14 and medium 12. From the spectral data collected with and without tissue 14, computer control 35 determines the optical properties of tissue 14.
In another preferred method of operation, after measuring the optical properties of medium 12, the scattering and absorptive properties of medium 12 are l0 matched by titration to the properties of tissue 14 so that, when inserted into field 25, tissue 14 does not cause perturbation of field 25. After matching the scattering and absorption coefficients of medium 12 to the coefficients of tissue 14, spectrophotometer 18 detects the same data with or without tissue 14. The known titrated values of /.ca* and /.~,8* are equal to the and ACS values of tissue 14. The matching process is performed by first matching wa and then ~8 or vice versa.
The described method is applicable to both in vivo and in vitro tissue examination. Tissue 14 may be a biopsy specimen enclosed in an optically transparent material or a portion of a human finger inserted into medium 12. The wavelength of light used by spectrophotometer 18 is selected depending on the tissue component of interest (e. g., hemoglobin, oxyhemoglobin, glucose, enzymes); it is within the scope of this invention to use multiple wavelengths.
The present invention envisions the use of different preferred embodiments of optical medium 12.
Referring to Fig. 2, a hollow cylinder 42 filled with medium 12 surrounds, for example, a finger 40 and prevents escape of introduced photons. The optical properties, pressure and volume of medium 12 are controlled by system 30 connected to cylinder 42 by tubes 32 and 34. The inside walls of cylinder 42 are made of a PCTlUS94100732 WO 94/16615 , ~1~4~~~
_ g _ pliable, optically transparent barrier 44. After insertion into cylinder 42, barrier 44 fits snugly around the finger. The dimension of inside barrier 44 is such that after finger 40 is withdrawn, medium 12 fills the volume of cylinder 42 completely. This enables both a background measurement of medium 12 and a,measurement of finger 40 in medium 12 in the same way as described in connection with Fig. 1. Optical field 25, controlled by the position of input port 19 and detection port 21, is either in transmission or reflection geometry.
Referring to Fig. 2B, in another embodiment, cylinder 42 is replaced by a set of cylinders 42A, 42B, 42C..., each containing medium 12 in a fluid or solid state with a constant preselected absorption and scattering coefficient. The solid optical medium is titanium oxide, or other scatterer, imbedded in an absorbing, pliable medium such as a gel.
A human finger is inserted into the individual cylinders, and the optical properties of the inserted finger are measured by spectrophotometer 18. Using the known optical properties of the cylinders and the input port- detection port geometry, the optical properties ( i . a . , ~,a and ~,8 ) of the finger can be matched to the properties of one of the cylinders.
The preferred embodiments of spectrophotometer 18 are a continuous wave spectrometer, a phase modulation spectrometer and a time-resolved spectrometer, all of them described in the above-cited documents.
System 10 operating with a dual wavelength continuous wave spectrometer is used, for example, as a finger oximeter. As shown in Fig. 2A, the vast majority of photons introduced into finger 40 are prevented to escape by surrounding medium 12. Thus, the introduced photons are either absorbed or reach detection port 21 and are registered by the detector. No error of counting the escaped photons as absorbed occurs. The background spectral data corresponding to each selected value of ~ua*
and ~B* of cylinder 42 are stored in the system that can match the values of ~.a and ~,8 of the finger and the cylinder for each wavelength. For the continuous wave spectrometer that operates at two wavelengths sensitive to hemoglobin (Hb) and oxyhemoglobin (Hb02) (e. g., 754nm and 816nm), the hemoglobin saturation (Y) is calculated by taking the ratio of absorption coefficients and using the following equation for the oxygen saturation:
38-18 ~a Y(X100$) _ ~ 54 25+3 ~a wherein the coefficients are determined from the extinction values of hemoglobin at 754 nm and 816 nm that are s~ = 0.38 c~ 1 mM'1, eHb = 0.18 cm 1mM'1, respectively, and the difference extinction coefficients between oxyhemoglobin and hemoglobin that are ~E~o_~ _ 0.025 cm-1 mM-1 and ~EHbo_Hb = 0.03 cm-1 mM-1, respectively.
As known to a person skilled in the art, in the hemoglobin saturation measurement the oximeter normalizes the detected data to eliminate fluctuations due to the changing blood volume. However, the volume changes can be used to detect the pulse rate.
Alternatively, a phase modulation spectrometer is used to measure the photon migration by detecting the intensity and the phase shift 8 of sinusoidally modulated light introduced at a distance of several centimeters from the detector. For tissue of a small volume, the optimal distance between the input port and the irradiation port is achieved using optical medium 12.
Furthermore, medium 12 substantially eliminates the photon escape.
W~ ~~l~ls The detected phase shift is directly related to the mean of the distribution of photon pathlengths shown in Fig. 2A. Photon migration theory predicts that the detected photons can be represented by a three dimensional "banana-shaped" distribution pattern in the reflection geometry or a "cigar-shaped" distribution pattern in the transmission geomatry. Inserting tissue 14 into the center of field 25 causes nonuniformities in the distribution of pathlengths, i.e:, the banana-shaped optical field 25 is nonuniform, if the tissue absorption properties are different from the properties of medium .12. If fca of, the tissue is smaller then that of the surrounding medium, the average pathlength <L> decreases since photons with longer pathlengths are more absorbed and vice versa. Thus, tissue 14 causes changes in the ' pathlength and the phase shift, 8.
Furthermore, the detected intensity provides a modulation index (M) that is an important measure of the absorption and scattering properties of a strongly scattering medium. The modulation index is determined as the ratio of the AC amplitude (Aa) to the sum of the AC
and DC (DC~) amplitude. ' A a~
' = I3?
A ~l + DC~' As described in Sevick et al. in Analytical Biochemistry Vol. 195, pp. 330-351, 1991, ~ for low modulation frequencies (i.e., 2rtf « ~Cac) the phase shift is a direct measure of the mean time of flight, <t>, i.e.,
In a further aspect, the invention provides a spectrophotometric method of examination of an object of interest using visible or infra-red radiation introduced to optical paths passing through the object, the method comprising the steps of:
(a) providing, at the object, optical means for limiting escape of photons or accounting for escaped photons from inside to outside of the object, (b) introducing into the object, at an optical input port, electromagnetic radiation of a selected wavelength in the visible or infra-red range, (c) detecting radiation that has migrated in the object from the input port to an optical detection port, and (d) determining an optical property of the object based on the changes between the introduced and the detected radiation.
A
In a further aspect, the invention provides a spectrophotometric method of examination of an object of interest using visible or infra-red radiation introduced to optical paths passing through the object, said method comprising the steps of:
(a) providing, at said objectr optical means for limiting escape of photons or providing retuzn paths for photons escaped from inside to outside of said object, (b} introducing into the object, at an optical input port, electromagnetic radiation of a wavelength in the visible or infra-xed range, photons of said radiation tnigxating inside of said object, (c} detecting photons of said radiation that has migrated in said object from said input port to an optical detection port, the detected radiation also including photons that returned from outside of sa~.d object into said object, and (d) determining an optical property of said object based'on the changes of properties of the introduced and the detected radiation.
In a further aspect, the invention pxovides a spectrophotometric system for examination of an object o~
interest using visible or infra-red radiation introduced to optzCal paths passing through the object, said system Comprising:
a spectrophotometer unit including a light source optically connected to an optical input port adapted to introduce photons of said radiation into the object, the introduced photons migrating inside of said object, and a light detector optically connected to an optical detection port adapted Co detect radiation that has migrated over optical paths in the object, optical means axranged at the object of interest and adapted to limit escape of the introduced photons or provide return paths far photons escaped from inside to outside of the object.
processing means, connected to said spectrophotometer unit, adapted to determine an optical property of the object based on the changes between the introduced and the detected radiation, the detected radiation also including photons that returned from outside of said object into said object.
Hrief Desarimtion o~ the cawing Fig. 1 is a diagrammatic view o! a spaatrophotometric system for examination of tissue of a relatively small dimension.
Figs. 2 and 2A show different views of a cylinder . for preventing escape of photons during speatrQphotometric measurements of a finger.
Fig. 2H shows a sat of ayliDderø of preselected optical properties far a finger oximetry.
Fig. 3 is a diagrammatic view of an optical fiber holder !or a spsctrophotometxia study of the head.
Fig. 4 is a diagramwdtic view of a TRS test system used for finger examiDat~op.
Pigs. 4A and 48 display measured values of the absorption coefficient seasured fn a test, and~Fig. 4C
displays their relative occurrence.
Figs. 4D and 4E display mgasured~values of the ' scattering coefficient and their relative occurrence respectiveiy.
Figs. 4P and 4G display calculated values of the hemoglobin saturation and their relative oaaurrenae, respectively.
wo 9mss~.s ,... ..., ~.rtJS9oioo~z w Referring to Fig. 1, ,a system 10 for examination of biological tissue of a relatively small volume, includes an optical medium 12 of selectable optical properties, a spectrophotometer 18, a titrimetric circulation system 30,. and computer control 35.
Biological tissue of interest 14, attached to a locator 15, is immersed in optical medium 12. Spectrophotometer 18 examines optical properties of medium 12 by employing visible or infra-red light conducted via light guides 20 and 22. Light guides 20 and 22, which in a preferred embodiment are optical fibers, are connected to alight source 18A and a light detector 23, respectively. Photons introduced at an optical input port 19 migrate in medium 12 through a scattering and absorptive path and are detected at a detection port 2l. The selectable fixed geometry of input port 19 and detection port 21 controls the migration path, i.e., optical field 25.
System 30 is adapted to change precisely the 2o scattering and absorptive properties of medium 12.
Medium 12 includes intralipid solution (made by Kabi Vitrum, Inc., Clapton, NC) that exhibits scattering properties depending on its concentration and carbon black India ink that exhibits absorptive properties. The scattering or absorptive properties of medium 12 can be either maintained constant and uniform by properly mixing the solution or can be changed almost continuously by changing the concentration of the constituents in titration system 30. Tubes 32 and 34 are adapted far continuous circulation of the solution.
In system operation, tissue 14 is first located away from optical field 25. Spectrophotometer 18 examines medium 12 in field region 25, and control 35 compares the detected data to the preselected values of the absorption coefficient (~.a) and the scattering WO 94/16615 _ ,~ PCT/US94/00732 coefficient (Ecs). Next, locator 15 positions tissue 14 into field 25 and spectrophotometer 18 measures the optical properties of tissue 14 and medium 12. From the spectral data collected with and without tissue 14, computer control 35 determines the optical properties of tissue 14.
In another preferred method of operation, after measuring the optical properties of medium 12, the scattering and absorptive properties of medium 12 are l0 matched by titration to the properties of tissue 14 so that, when inserted into field 25, tissue 14 does not cause perturbation of field 25. After matching the scattering and absorption coefficients of medium 12 to the coefficients of tissue 14, spectrophotometer 18 detects the same data with or without tissue 14. The known titrated values of /.ca* and /.~,8* are equal to the and ACS values of tissue 14. The matching process is performed by first matching wa and then ~8 or vice versa.
The described method is applicable to both in vivo and in vitro tissue examination. Tissue 14 may be a biopsy specimen enclosed in an optically transparent material or a portion of a human finger inserted into medium 12. The wavelength of light used by spectrophotometer 18 is selected depending on the tissue component of interest (e. g., hemoglobin, oxyhemoglobin, glucose, enzymes); it is within the scope of this invention to use multiple wavelengths.
The present invention envisions the use of different preferred embodiments of optical medium 12.
Referring to Fig. 2, a hollow cylinder 42 filled with medium 12 surrounds, for example, a finger 40 and prevents escape of introduced photons. The optical properties, pressure and volume of medium 12 are controlled by system 30 connected to cylinder 42 by tubes 32 and 34. The inside walls of cylinder 42 are made of a PCTlUS94100732 WO 94/16615 , ~1~4~~~
_ g _ pliable, optically transparent barrier 44. After insertion into cylinder 42, barrier 44 fits snugly around the finger. The dimension of inside barrier 44 is such that after finger 40 is withdrawn, medium 12 fills the volume of cylinder 42 completely. This enables both a background measurement of medium 12 and a,measurement of finger 40 in medium 12 in the same way as described in connection with Fig. 1. Optical field 25, controlled by the position of input port 19 and detection port 21, is either in transmission or reflection geometry.
Referring to Fig. 2B, in another embodiment, cylinder 42 is replaced by a set of cylinders 42A, 42B, 42C..., each containing medium 12 in a fluid or solid state with a constant preselected absorption and scattering coefficient. The solid optical medium is titanium oxide, or other scatterer, imbedded in an absorbing, pliable medium such as a gel.
A human finger is inserted into the individual cylinders, and the optical properties of the inserted finger are measured by spectrophotometer 18. Using the known optical properties of the cylinders and the input port- detection port geometry, the optical properties ( i . a . , ~,a and ~,8 ) of the finger can be matched to the properties of one of the cylinders.
The preferred embodiments of spectrophotometer 18 are a continuous wave spectrometer, a phase modulation spectrometer and a time-resolved spectrometer, all of them described in the above-cited documents.
System 10 operating with a dual wavelength continuous wave spectrometer is used, for example, as a finger oximeter. As shown in Fig. 2A, the vast majority of photons introduced into finger 40 are prevented to escape by surrounding medium 12. Thus, the introduced photons are either absorbed or reach detection port 21 and are registered by the detector. No error of counting the escaped photons as absorbed occurs. The background spectral data corresponding to each selected value of ~ua*
and ~B* of cylinder 42 are stored in the system that can match the values of ~.a and ~,8 of the finger and the cylinder for each wavelength. For the continuous wave spectrometer that operates at two wavelengths sensitive to hemoglobin (Hb) and oxyhemoglobin (Hb02) (e. g., 754nm and 816nm), the hemoglobin saturation (Y) is calculated by taking the ratio of absorption coefficients and using the following equation for the oxygen saturation:
38-18 ~a Y(X100$) _ ~ 54 25+3 ~a wherein the coefficients are determined from the extinction values of hemoglobin at 754 nm and 816 nm that are s~ = 0.38 c~ 1 mM'1, eHb = 0.18 cm 1mM'1, respectively, and the difference extinction coefficients between oxyhemoglobin and hemoglobin that are ~E~o_~ _ 0.025 cm-1 mM-1 and ~EHbo_Hb = 0.03 cm-1 mM-1, respectively.
As known to a person skilled in the art, in the hemoglobin saturation measurement the oximeter normalizes the detected data to eliminate fluctuations due to the changing blood volume. However, the volume changes can be used to detect the pulse rate.
Alternatively, a phase modulation spectrometer is used to measure the photon migration by detecting the intensity and the phase shift 8 of sinusoidally modulated light introduced at a distance of several centimeters from the detector. For tissue of a small volume, the optimal distance between the input port and the irradiation port is achieved using optical medium 12.
Furthermore, medium 12 substantially eliminates the photon escape.
W~ ~~l~ls The detected phase shift is directly related to the mean of the distribution of photon pathlengths shown in Fig. 2A. Photon migration theory predicts that the detected photons can be represented by a three dimensional "banana-shaped" distribution pattern in the reflection geometry or a "cigar-shaped" distribution pattern in the transmission geomatry. Inserting tissue 14 into the center of field 25 causes nonuniformities in the distribution of pathlengths, i.e:, the banana-shaped optical field 25 is nonuniform, if the tissue absorption properties are different from the properties of medium .12. If fca of, the tissue is smaller then that of the surrounding medium, the average pathlength <L> decreases since photons with longer pathlengths are more absorbed and vice versa. Thus, tissue 14 causes changes in the ' pathlength and the phase shift, 8.
Furthermore, the detected intensity provides a modulation index (M) that is an important measure of the absorption and scattering properties of a strongly scattering medium. The modulation index is determined as the ratio of the AC amplitude (Aa) to the sum of the AC
and DC (DC~) amplitude. ' A a~
' = I3?
A ~l + DC~' As described in Sevick et al. in Analytical Biochemistry Vol. 195, pp. 330-351, 1991, ~ for low modulation frequencies (i.e., 2rtf « ~Cac) the phase shift is a direct measure of the mean time of flight, <t>, i.e.,
6-~2~rf<t>. In a medium wherein all photons travel at a constant speed, c, the phase shift describes the effective, mean pathlength 8 -~ 2nf<L>/c. Here, all pathlengths are weighted equally. The determined WO 94/16615 - ~ PCT/US94/00732 path~ength is used in Beer-Lambert equation for determination of the absorption properties.
As the modulation frequency increases, the shorter pathlengths become more heavily weighted. At frequencies (i.e. 2nf » sac), the phase shift is no longer a good measure of the distribution of pathlengths and is directly proportional to the absorption coefficient, fca, and the effective scattering coefficient, (1-g)~~CB
aP~ - 9 L~s. {1 - 4TCf}
Since the effective scattering coefficient is wavelength independent, ratio of the phase shifts measured at two wavelengths can be written _Pa~
e~z _ 8Qz Paz wherein 60~' is the phase shift at the measured wavelength arising from the scattering and background absorption.
The ratio of the absorption coefficients is used, for example, for determination of the tissue saturation, Y.
A dual frequency, dual wavelength phase modulation spectrometer can be used to determine the saturation by eliminating 60. The ratio of absorption coefficients is expressed as a function of the phase shifts measured at different frequencies and wavelengths.
cefl~l/,/fi) - (V f2~1/~) t6) ce fl~=/,~) - cefZ~Z/,~) , In another preferred embodiment, a time-resolved spectrometer (TRS-pulse) introduces, at input port 19, pulses of light on the order of less than a picosecond.
Photons traveling through a distribution of migration pathlengths 25 are collected at the detection port 21.
The intensity of detected light in the reflectance geometry, R(p,t), (or the transmittance geometry T(p,d,t)) was determined by solving the diffusion equation in an infinite media as a Green's function with near infinite boundary conditions. Due to the semi-s infinite media condition in the reflectance geometry, the separation of the input and output ports must be on the order of several centimeters to use the following equation.
d logeR(p, t) - -5 - PaC + ~ (7) at 2t 4DCt For t -~ ~ the absorption coefficient ~a is determined as l im d logeR ( p . t) =-I~ac c-~ d t _ wherein p is the separation between input and detection ports and c is speed of light in the medium. The effective scattering coefficient (1-g) ~8 is determined as (2-g) E1S= 2 (4~iec2tm~ax+lOCt~) -Eia (9) P
wherein tmax is the delay time at which the detected reflectance time profile (R(p,t) - I(t)) reaches maximum.
The right hand side of Eq. 7 is the decay slope of the arrival time of the modified pulses. The absorption coefficient is quantified by evaluating the decaying slope of the detected pulse, as described in Eq. 7. The effective scattering coefficient, (1-g)~~CB, is determined from Eq. 8. For the known ~a and ~.~,8 and the input port, output port geometry, the system has a unique time profile I(t). The stored profile is compared to the time profile detected for the introduced tissue to obtain a difference profile that possesses the scattering and absorption coefficients of tissue 14. Alternatively, N-a ~I~~.J6~
WO 94/16615 PCTlUS94/00732 and ~.8 of medium 12 and tissue 14 are matched by varying the scattering and absorptive properties of medium 12 so that the detected time profile is not altered by introducing tissue 14.
The TRS system can be used to calibrate a CW
oximeter to quantify the measured data. To account for the difference between the geometric distance (p) of the input port and the detection port and the pathlength (<L>), some oximeters use a modified Beer-Lambert equation with a differential pathlength factor (DPF) as follows absorbance=DPF.e.[C) (lo) However, the differential pathlength factor can not be precisely determined by the CW oximeters since it depends on the pathlength. The TRS determines DPF using the absorption (~Ca) and scattering (~e) coefficients as follows:
DPF=~ (1-9) ~$ (ll) An alternative embodiment of the escape preventing optical medium used for examining the head of a neonate (46) is an optrode holder 45, shown in Fig. 3. Optical fibers 20 and 22 are projected into a solid scattering material 47, such as Styrofoam, which affords a return pathway for escaping photons 48. The pathlength of the migrating photons in the tissue is much longer since the photons return to the tissue by the scattering materials, as shown by the zig-zag arrows 48. Thus, the banana-shaped pattern will penetrate more deeply and meaningful spectroscopic data can be obtained at smaller input-output fiber separations without the danger of photon leakage or "short" by substantially direct pathways.
Different embodiments of system 10 are adapted to perform either a single measurement or a continuous, time-dependent monitoring of the selected physiological property. Visual display for continuous monitoring of the measured values may be added. Furthermore, a warning signal may be issued when the measured value equals to a preselected value.
$YAMPLB
Referring to Fig. 4, in a test study, a TRS-pulse spectrophotometer was used for quantitative determination of the scattering and absorptive properties of a human finger. To create semi-infinite boundary conditions, examined index finger 40 was immersed into a relatively large volume of intralipid solution 52 with carbon l5 containing India ink. A commercially available intralipid of about 20% concentration Was diluted to about 0.5%-2.5% concentration to produce surrounding medium 52. The concentration of the intralipid determines the scattering properties of the solution and the amount of the India ink governs the absorptive properties. Selected amounts of the diluted carbon black ink were added into the matching medium according to the needs. In the test, a 1.4 liter cylinder container 51 of about 15 cm in diameter and 8 cm in height was used to hold matching medium 52. Almost all of the measurements were performed on the index finger of twenty five healthy volunteers (male and female) that included Caucasian, Asian, and African-American population. Fiber ends 5?
and 59 of. optical fibers 56 and 60 inserted into the host medium several millimeters below the solution surface and maintained in a separation of 3 cm on both sides of examined finger 40. Finger 40 was immersed about 5-6 cm below the surface of surrounding medium 52 in a manner to be located in an optical field defined by the immersed 2.~~4-Ofi WO 94/16615 - PCT/US94/00~32 ends,57 and 59. This prevented most photons from being transmitted to the surface.
The dual wavelength TRS system with a 5 MHz repetition rate injected 100-ps pulses (61) of red (670 nm) or near-infrared (750 and 830 nm) light created in pulser 62 into medium 52. Optical input fiber 56 of a 1 hum diameter and optical output fiber 60 of a 2mm diameter were used. The detector consisted of a micro-channel-plate photomultiplier tube 64 (MCP-PMT) with a time resolution of 150 ps connected to a constant fraction discriminator (CFD) 66. The single photon counting system included a time amplitude converter (TAC) 68 and computer 70 for registering digitized data. The TRS
measurements were taken both in the absence and~in the presence of finger 40.
The above-described matching method was used by first increasing the absorption coefficient ~a(h) of surrounding medium 52 by adding the diluted black ink.
Once the appropriate absorber concentration was determined, the second titration process was used to determine M,8'(h) by increasing the concentration of the intralipid.
The TRS data were deconvoluted with the instrumental function that compensates for the instrument's response. The values of E.i,a, E.i,e' , and To (i.e., the laser pulse injection time) were least-square fitted. The absorption coefficient ~,a and the scattering coefficient ~.cB' were expressed using 1og10 base, which can be converted to loge base simply by multiplying 2.303.
(NOTE: for ~,B calculated by Eq. 9 this conversion cannot be used.) Fig. 4A displays the absorption coefficients obtained on fourteen people, (four Caucasian, five Asians, and five African-American) with the matching method and direct measurement, respectively, at 670 nm WO 94/16615 ~ ~ PCT/US94/00732 wavelength and a 2.5 cm interfiber distance. The relative values of ~a obtained in the matching measurement varied from 0.05 cm-1 to 0.08 cm-1, apparently randomly among the three populations; however, the values in the direct measurement varied even more. The direct measurement gives much higher values of wa than the values obtained with the matching method which may be due to photon escape from the finger surface when the optical fibers are attached to the measured finger directly.
Fig. 4B shows the absorption values measured for a different group of volunteers. Fig. 4C shows the values of ~a as a function of the number of observations. In this study, no relationship was found between the finger diameter and the absorption coefficients fi,a indicating that the size of the finger has no effect on Eca.
Fig. 4D display ~8 at measured 670 nm by the matching method for the fourteen individuals of Fig. 4A.
The scattering data are summarized in Fig. 4E as a function of the relative occurrence of ~B. The mean value is 6.26 cr~l and the standard error is 0.64 c~ 1 with an approximately gaussian distribution.
The quantitative hemoglobin saturation of the finger was measured at 670 nm and 750 nm. Since the contribution of water absorption at 750 nm is relatively high, it was necessary to subtract water absorption background from the calculated value of N,a. For this purpose, we assumed the absorption coefficients of water at 750 nm and 670 nm equal to 0.004 1/cm and 0.026 1/cm, respectively. The background corrected values of ~,a and the corresponding hemoglobin saturation values are shown in the following table and plotted in Figs. 4F and 4G.
,~~ ~~..~s~
Subject E.ca670 (l~Cm)~,~,a750 (l~Cm)~,~,a670~~a750y (%) 1 0.05119 0.04453 1.14948 83.88 2 0.0467 0.04386 1.0647 87.47 3 0.0578 0.04424 1.30663 76.20 4 0.06276 0.05204 1.20588 81.29 5 0.05743 0.04286 1.339860 74.38 6 0.05045 0.04275 1.18023 82.49
As the modulation frequency increases, the shorter pathlengths become more heavily weighted. At frequencies (i.e. 2nf » sac), the phase shift is no longer a good measure of the distribution of pathlengths and is directly proportional to the absorption coefficient, fca, and the effective scattering coefficient, (1-g)~~CB
aP~ - 9 L~s. {1 - 4TCf}
Since the effective scattering coefficient is wavelength independent, ratio of the phase shifts measured at two wavelengths can be written _Pa~
e~z _ 8Qz Paz wherein 60~' is the phase shift at the measured wavelength arising from the scattering and background absorption.
The ratio of the absorption coefficients is used, for example, for determination of the tissue saturation, Y.
A dual frequency, dual wavelength phase modulation spectrometer can be used to determine the saturation by eliminating 60. The ratio of absorption coefficients is expressed as a function of the phase shifts measured at different frequencies and wavelengths.
cefl~l/,/fi) - (V f2~1/~) t6) ce fl~=/,~) - cefZ~Z/,~) , In another preferred embodiment, a time-resolved spectrometer (TRS-pulse) introduces, at input port 19, pulses of light on the order of less than a picosecond.
Photons traveling through a distribution of migration pathlengths 25 are collected at the detection port 21.
The intensity of detected light in the reflectance geometry, R(p,t), (or the transmittance geometry T(p,d,t)) was determined by solving the diffusion equation in an infinite media as a Green's function with near infinite boundary conditions. Due to the semi-s infinite media condition in the reflectance geometry, the separation of the input and output ports must be on the order of several centimeters to use the following equation.
d logeR(p, t) - -5 - PaC + ~ (7) at 2t 4DCt For t -~ ~ the absorption coefficient ~a is determined as l im d logeR ( p . t) =-I~ac c-~ d t _ wherein p is the separation between input and detection ports and c is speed of light in the medium. The effective scattering coefficient (1-g) ~8 is determined as (2-g) E1S= 2 (4~iec2tm~ax+lOCt~) -Eia (9) P
wherein tmax is the delay time at which the detected reflectance time profile (R(p,t) - I(t)) reaches maximum.
The right hand side of Eq. 7 is the decay slope of the arrival time of the modified pulses. The absorption coefficient is quantified by evaluating the decaying slope of the detected pulse, as described in Eq. 7. The effective scattering coefficient, (1-g)~~CB, is determined from Eq. 8. For the known ~a and ~.~,8 and the input port, output port geometry, the system has a unique time profile I(t). The stored profile is compared to the time profile detected for the introduced tissue to obtain a difference profile that possesses the scattering and absorption coefficients of tissue 14. Alternatively, N-a ~I~~.J6~
WO 94/16615 PCTlUS94/00732 and ~.8 of medium 12 and tissue 14 are matched by varying the scattering and absorptive properties of medium 12 so that the detected time profile is not altered by introducing tissue 14.
The TRS system can be used to calibrate a CW
oximeter to quantify the measured data. To account for the difference between the geometric distance (p) of the input port and the detection port and the pathlength (<L>), some oximeters use a modified Beer-Lambert equation with a differential pathlength factor (DPF) as follows absorbance=DPF.e.[C) (lo) However, the differential pathlength factor can not be precisely determined by the CW oximeters since it depends on the pathlength. The TRS determines DPF using the absorption (~Ca) and scattering (~e) coefficients as follows:
DPF=~ (1-9) ~$ (ll) An alternative embodiment of the escape preventing optical medium used for examining the head of a neonate (46) is an optrode holder 45, shown in Fig. 3. Optical fibers 20 and 22 are projected into a solid scattering material 47, such as Styrofoam, which affords a return pathway for escaping photons 48. The pathlength of the migrating photons in the tissue is much longer since the photons return to the tissue by the scattering materials, as shown by the zig-zag arrows 48. Thus, the banana-shaped pattern will penetrate more deeply and meaningful spectroscopic data can be obtained at smaller input-output fiber separations without the danger of photon leakage or "short" by substantially direct pathways.
Different embodiments of system 10 are adapted to perform either a single measurement or a continuous, time-dependent monitoring of the selected physiological property. Visual display for continuous monitoring of the measured values may be added. Furthermore, a warning signal may be issued when the measured value equals to a preselected value.
$YAMPLB
Referring to Fig. 4, in a test study, a TRS-pulse spectrophotometer was used for quantitative determination of the scattering and absorptive properties of a human finger. To create semi-infinite boundary conditions, examined index finger 40 was immersed into a relatively large volume of intralipid solution 52 with carbon l5 containing India ink. A commercially available intralipid of about 20% concentration Was diluted to about 0.5%-2.5% concentration to produce surrounding medium 52. The concentration of the intralipid determines the scattering properties of the solution and the amount of the India ink governs the absorptive properties. Selected amounts of the diluted carbon black ink were added into the matching medium according to the needs. In the test, a 1.4 liter cylinder container 51 of about 15 cm in diameter and 8 cm in height was used to hold matching medium 52. Almost all of the measurements were performed on the index finger of twenty five healthy volunteers (male and female) that included Caucasian, Asian, and African-American population. Fiber ends 5?
and 59 of. optical fibers 56 and 60 inserted into the host medium several millimeters below the solution surface and maintained in a separation of 3 cm on both sides of examined finger 40. Finger 40 was immersed about 5-6 cm below the surface of surrounding medium 52 in a manner to be located in an optical field defined by the immersed 2.~~4-Ofi WO 94/16615 - PCT/US94/00~32 ends,57 and 59. This prevented most photons from being transmitted to the surface.
The dual wavelength TRS system with a 5 MHz repetition rate injected 100-ps pulses (61) of red (670 nm) or near-infrared (750 and 830 nm) light created in pulser 62 into medium 52. Optical input fiber 56 of a 1 hum diameter and optical output fiber 60 of a 2mm diameter were used. The detector consisted of a micro-channel-plate photomultiplier tube 64 (MCP-PMT) with a time resolution of 150 ps connected to a constant fraction discriminator (CFD) 66. The single photon counting system included a time amplitude converter (TAC) 68 and computer 70 for registering digitized data. The TRS
measurements were taken both in the absence and~in the presence of finger 40.
The above-described matching method was used by first increasing the absorption coefficient ~a(h) of surrounding medium 52 by adding the diluted black ink.
Once the appropriate absorber concentration was determined, the second titration process was used to determine M,8'(h) by increasing the concentration of the intralipid.
The TRS data were deconvoluted with the instrumental function that compensates for the instrument's response. The values of E.i,a, E.i,e' , and To (i.e., the laser pulse injection time) were least-square fitted. The absorption coefficient ~,a and the scattering coefficient ~.cB' were expressed using 1og10 base, which can be converted to loge base simply by multiplying 2.303.
(NOTE: for ~,B calculated by Eq. 9 this conversion cannot be used.) Fig. 4A displays the absorption coefficients obtained on fourteen people, (four Caucasian, five Asians, and five African-American) with the matching method and direct measurement, respectively, at 670 nm WO 94/16615 ~ ~ PCT/US94/00732 wavelength and a 2.5 cm interfiber distance. The relative values of ~a obtained in the matching measurement varied from 0.05 cm-1 to 0.08 cm-1, apparently randomly among the three populations; however, the values in the direct measurement varied even more. The direct measurement gives much higher values of wa than the values obtained with the matching method which may be due to photon escape from the finger surface when the optical fibers are attached to the measured finger directly.
Fig. 4B shows the absorption values measured for a different group of volunteers. Fig. 4C shows the values of ~a as a function of the number of observations. In this study, no relationship was found between the finger diameter and the absorption coefficients fi,a indicating that the size of the finger has no effect on Eca.
Fig. 4D display ~8 at measured 670 nm by the matching method for the fourteen individuals of Fig. 4A.
The scattering data are summarized in Fig. 4E as a function of the relative occurrence of ~B. The mean value is 6.26 cr~l and the standard error is 0.64 c~ 1 with an approximately gaussian distribution.
The quantitative hemoglobin saturation of the finger was measured at 670 nm and 750 nm. Since the contribution of water absorption at 750 nm is relatively high, it was necessary to subtract water absorption background from the calculated value of N,a. For this purpose, we assumed the absorption coefficients of water at 750 nm and 670 nm equal to 0.004 1/cm and 0.026 1/cm, respectively. The background corrected values of ~,a and the corresponding hemoglobin saturation values are shown in the following table and plotted in Figs. 4F and 4G.
,~~ ~~..~s~
Subject E.ca670 (l~Cm)~,~,a750 (l~Cm)~,~,a670~~a750y (%) 1 0.05119 0.04453 1.14948 83.88 2 0.0467 0.04386 1.0647 87.47 3 0.0578 0.04424 1.30663 76.20 4 0.06276 0.05204 1.20588 81.29 5 0.05743 0.04286 1.339860 74.38 6 0.05045 0.04275 1.18023 82.49
7 0.05936 0.05234 1.13417 84.55
8 0.0493 0.04187 1.17756 82.61
9 0.05488 0.0513 1.06981 87.26
10 0.05012 0.0457 1.09662 86.16
11 0.05992 0.04895 1.22418 80.41
12 0.04848 0.04492 1.07935 86.87
13 0.05206 0.05207 0.99973 90.01
14 0.6463 0.05608 1.15249 83.74
Claims (26)
1. A spectrophotometric method of examination of an object of interest using visible or infra-red radiation introduced to optical paths passing through the object, said method comprising the steps of:
(a) providing, at said object, optical means for limiting escape of photons or providing return paths for photons escaped from inside to outside of said object, (b) introducing into the object, at an optical input port, electromagnetic radiation of a wavelength in the visible or infra-red range, photons of said radiation migrating inside of said object, (c) detecting photons of said radiation that has migrated in said object from said input port to an optical detection port, the detected radiation also including photons that returned from outside of said object into said object, and (d) determining an optical property of said object based on the changes of properties of the introduced and the detected radiation.
(a) providing, at said object, optical means for limiting escape of photons or providing return paths for photons escaped from inside to outside of said object, (b) introducing into the object, at an optical input port, electromagnetic radiation of a wavelength in the visible or infra-red range, photons of said radiation migrating inside of said object, (c) detecting photons of said radiation that has migrated in said object from said input port to an optical detection port, the detected radiation also including photons that returned from outside of said object into said object, and (d) determining an optical property of said object based on the changes of properties of the introduced and the detected radiation.
2. The spectrophotometric method of claim 1 wherein said object is biological tissue of a relatively small volume.
3. The spectrophotometric method of claim 2, wherein said biological tissue occupies a part of said optical paths between said optical input port and said optical detection port and said optical means creates a tissue-medium optical path.
4. The spectrophotometric method of claim 1, 2 or 3 wherein said optical means comprise an optical medium at least partially surrounding said object, said optical medium having selectable optical property.
5. The spectrophotometric method of claim 1, 2 or 3 wherein said optical means comprise an optical medium at least partially surrounding said object, said medium having at least one optical property substantially matched to the optical property of said object.
6. The spectrophotometric method of claim 5 wherein said optical property of said optical medium is an absorption coefficient or a scattering coefficient.
7. The spectrophotometric method of claim 1, 2 or 3, wherein said determining step (d) comprises:
(e) selecting optical means comprising an optical medium with at least one optical property comparable to the optical property of Said object, (f) measuring the optical property of said object by performing said (b) and (c) steps, (g) selecting another optical means comprising an optical. medium with at least one optical property matched closer to the corresponding optical property of said object, and (h) repeating iteratively said (f) and (g) steps until the optical property of said optical medium is substantially matched to the optical property of said object.
(e) selecting optical means comprising an optical medium with at least one optical property comparable to the optical property of Said object, (f) measuring the optical property of said object by performing said (b) and (c) steps, (g) selecting another optical means comprising an optical. medium with at least one optical property matched closer to the corresponding optical property of said object, and (h) repeating iteratively said (f) and (g) steps until the optical property of said optical medium is substantially matched to the optical property of said object.
8. The spectrophotometric method of claim 1, 2 or 3, wherein said determining step (a) comprises:
(e) introducing known changes in the scattering property or the absorptive property of said optical medium.
(f) measuring the optical property of said object by performing said (b) and (c) steps, (g) introducing additional known changes in the scattering property or the absorptive property of said optical medium to approximate at least one said property to the optical property of said object, and (h) repeating iteratively said (f) and (g) steps until at least one of saa.d optical properties of said optical medium is substantially matched to the corresponding optical property of said object.
(e) introducing known changes in the scattering property or the absorptive property of said optical medium.
(f) measuring the optical property of said object by performing said (b) and (c) steps, (g) introducing additional known changes in the scattering property or the absorptive property of said optical medium to approximate at least one said property to the optical property of said object, and (h) repeating iteratively said (f) and (g) steps until at least one of saa.d optical properties of said optical medium is substantially matched to the corresponding optical property of said object.
9. The spectrophotometric method of claim 1, 2 or 3, wherein. said radiation of said introduced wavelength is continuous wave low-frequency radiation.
10. The spectrophotometric method of claim 1, 2 or 3, wherein said radiation of said introduced wavelength is continuous wave radiation modulated by a carrier waveform of a frequency on the order of 10 8 Hz.
11. The spectrophotometric method of claim 1, 2 or 3, wherein said radiation of said introduced wavelength radiation of pulses having duration on the order of a nanosecond or less.
12. The spectrophotometric method of claim 1, 2 or 3, performed in vivo wherein said object is biological tissue and said optical property is related to hemoglobin oxygenation, glucose or enzyme levels in said tissue.
13. The spectrophotometric method of claim 1, 2 or 3.
wherein said object is a human finger, the head or a biopsy specimen.
wherein said object is a human finger, the head or a biopsy specimen.
14. A spectrophotometric system for examination of an object of interest using visible or infra-red radiation introduced to optical paths passing through the object, said system comprising:
a spectrophotometer unit including a light source optically connected to an optical input port adapted to introduce photons of said radiation into the object, the introduced photons migrating inside of said object, and a light detector optically connected to an optical detection port adapted to detect radiation that has migrated over optical paths in the object, optical means arranged at the object of interest and adapted to limit escape of the introduced photons or provide return paths for photons escaped from inside to outside of the object, processing means, connected to said spectrophotometer unit, adapted to determine an optical property of the object based on the changes between the introduced and the detected radiation, the detected radiation also including photons that returned from outside of said object into said object.
a spectrophotometer unit including a light source optically connected to an optical input port adapted to introduce photons of said radiation into the object, the introduced photons migrating inside of said object, and a light detector optically connected to an optical detection port adapted to detect radiation that has migrated over optical paths in the object, optical means arranged at the object of interest and adapted to limit escape of the introduced photons or provide return paths for photons escaped from inside to outside of the object, processing means, connected to said spectrophotometer unit, adapted to determine an optical property of the object based on the changes between the introduced and the detected radiation, the detected radiation also including photons that returned from outside of said object into said object.
15. The spectrophotometric system of claim 14 wherein said object is biological tissue of a small volume.
16. The spectrophotometric system of claim 15 wherein said biological tissue occupies a part of an optical path between said optical input port and said optical detection port and said optical means creates a tissue-medium optical path.
17. The spectrophotometric system of claim 14, 15 or 16 wherein said optical means comprise an optical medium, at least partially surrounding said object, having a selectable optical property.
18. The spectrophotometric system of claim 14, 15 or 16 wherein said optical means comprise an optical medium at least partially surrounding said object, said optical medium having at least one optical property substantially matched to the corresponding optical property of said object.
19. The spectrophotometric system of claim 18 wherein said optical medium includes a fluid or a solid.
20. The spectrophotometric system of claim 18, wherein said determined optical property of the object is an absorption coefficient or a scattering coefficient.
21. The spectrophotometric system of claim 14, 15 or 16, further comprising another optical medium with different scattering or absorptive properties approximating the scattering or absorptive properties of said object.
22. The spectrophotometric system of claim 14, 15 or 16, wherein said object is biological tissue and said determined optical property is related to hemoglobin oxygenation, glucose or enzyme levels in said tissue.
23. The spectrophotometric system of claim 15 or 18, wherein said object is a human finger, the head or a biopsy specimen.
24. The spectrophotometric system of claim 14, 15 or 16 wherein said spectrophotometer unit is a continuous wave spectrophotometer utilizing low frequency radiation.
25. The spectrophotometric system of claim 14, 15 or 16, wherein said spectrophotometer unit is a phase modulation spectrophotometer and said introduced radiation is modulated by a carrier waveform of a frequency on the order of 10 8 Hz.
26. The spectrophotometric system of claim 14, 15 or 16, wherein said spectrophotometer unit is a time resolved spectrophotometer and said introduced radiation comprises radiation pulses on the order of a nanosecond or less.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/006,233 US5402778A (en) | 1993-01-19 | 1993-01-19 | Spectrophotometric examination of tissue of small dimension |
US08/006,233 | 1993-01-19 | ||
PCT/US1994/000732 WO1994016615A1 (en) | 1993-01-19 | 1994-01-19 | Spectrophotometric examination of tissue of small dimension |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2154062A1 CA2154062A1 (en) | 1994-08-04 |
CA2154062C true CA2154062C (en) | 2005-04-05 |
Family
ID=21719922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002154062A Expired - Lifetime CA2154062C (en) | 1993-01-19 | 1994-01-19 | Spectrophotometric examination of tissue of small dimension |
Country Status (7)
Country | Link |
---|---|
US (1) | US5402778A (en) |
EP (1) | EP0682495B1 (en) |
JP (1) | JPH08509287A (en) |
CN (1) | CN1039382C (en) |
CA (1) | CA2154062C (en) |
DE (1) | DE69429426T2 (en) |
WO (1) | WO1994016615A1 (en) |
Families Citing this family (137)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6246892B1 (en) * | 1991-01-24 | 2001-06-12 | Non-Invasive Technology | Phase modulation spectroscopy |
US6263221B1 (en) * | 1991-01-24 | 2001-07-17 | Non-Invasive Technology | Quantitative analyses of biological tissue using phase modulation spectroscopy |
US5853370A (en) * | 1996-09-13 | 1998-12-29 | Non-Invasive Technology, Inc. | Optical system and method for non-invasive imaging of biological tissue |
US6397099B1 (en) | 1992-05-18 | 2002-05-28 | Non-Invasive Technology, Inc. | Non-invasive imaging of biological tissue |
US5492118A (en) * | 1993-12-16 | 1996-02-20 | Board Of Trustees Of The University Of Illinois | Determining material concentrations in tissues |
US6662033B2 (en) | 1994-04-01 | 2003-12-09 | Nellcor Incorporated | Pulse oximeter and sensor optimized for low saturation |
US6618614B1 (en) | 1995-01-03 | 2003-09-09 | Non-Invasive Technology, Inc. | Optical examination device, system and method |
DE69627477T2 (en) * | 1995-01-03 | 2004-03-18 | Non-Invasive Technology, Inc. | OPTICAL COUPLING DEVICE FOR IN-VIVO EXAMINATION OF BIOLOGICAL TISSUES |
US6152876A (en) | 1997-04-18 | 2000-11-28 | Rio Grande Medical Technologies, Inc. | Method for non-invasive blood analyte measurement with improved optical interface |
US5655530A (en) * | 1995-08-09 | 1997-08-12 | Rio Grande Medical Technologies, Inc. | Method for non-invasive blood analyte measurement with improved optical interface |
US6212424B1 (en) | 1998-10-29 | 2001-04-03 | Rio Grande Medical Technologies, Inc. | Apparatus and method for determination of the adequacy of dialysis by non-invasive near-infrared spectroscopy |
US6240306B1 (en) | 1995-08-09 | 2001-05-29 | Rio Grande Medical Technologies, Inc. | Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration |
GB9526309D0 (en) * | 1995-12-22 | 1996-02-21 | Cme Telemetrix Inc A Company O | Integrating cavity for spectroscopic measurement in light scattering samples |
US5995857A (en) * | 1996-07-01 | 1999-11-30 | Toomim; I. Hershel | Biofeedback of human central nervous system activity using radiation detection |
EP0857033B1 (en) * | 1996-08-14 | 2004-01-02 | Koninklijke Philips Electronics N.V. | Forming an image of a turbid medium using a fluid to reduce boundary effects |
US5830136A (en) * | 1996-10-31 | 1998-11-03 | Nellcor Puritan Bennett Incorporated | Gel pad optical sensor |
US6119031A (en) | 1996-11-21 | 2000-09-12 | Boston Scientific Corporation | Miniature spectrometer |
US5963658A (en) * | 1997-01-27 | 1999-10-05 | University Of North Carolina | Method and apparatus for detecting an abnormality within a host medium |
US5823966A (en) * | 1997-05-20 | 1998-10-20 | Buchert; Janusz Michal | Non-invasive continuous blood glucose monitoring |
US6560352B2 (en) | 1999-10-08 | 2003-05-06 | Lumidigm, Inc. | Apparatus and method of biometric identification or verification of individuals using optical spectroscopy |
US6628809B1 (en) | 1999-10-08 | 2003-09-30 | Lumidigm, Inc. | Apparatus and method for identification of individuals by near-infrared spectrum |
US7890158B2 (en) * | 2001-06-05 | 2011-02-15 | Lumidigm, Inc. | Apparatus and method of biometric determination using specialized optical spectroscopy systems |
IL121079A0 (en) * | 1997-06-15 | 1997-11-20 | Spo Medical Equipment Ltd | Physiological stress detector device and method |
US6324418B1 (en) | 1997-09-29 | 2001-11-27 | Boston Scientific Corporation | Portable tissue spectroscopy apparatus and method |
US6096065A (en) | 1997-09-29 | 2000-08-01 | Boston Scientific Corporation | Sheath for tissue spectroscopy |
US5984861A (en) | 1997-09-29 | 1999-11-16 | Boston Scientific Corporation | Endofluorescence imaging module for an endoscope |
US6238348B1 (en) | 1997-07-22 | 2001-05-29 | Scimed Life Systems, Inc. | Miniature spectrometer system and method |
US6185443B1 (en) | 1997-09-29 | 2001-02-06 | Boston Scientific Corporation | Visible display for an interventional device |
US6091984A (en) * | 1997-10-10 | 2000-07-18 | Massachusetts Institute Of Technology | Measuring tissue morphology |
US6687532B2 (en) | 1997-12-12 | 2004-02-03 | Hamamatsu Photonics K.K. | Optical CT apparatus and image reconstructing method |
US6055451A (en) | 1997-12-12 | 2000-04-25 | Spectrx, Inc. | Apparatus and method for determining tissue characteristics |
US20030135122A1 (en) * | 1997-12-12 | 2003-07-17 | Spectrx, Inc. | Multi-modal optical tissue diagnostic system |
US6289229B1 (en) | 1998-01-20 | 2001-09-11 | Scimed Life Systems, Inc. | Readable probe array for in vivo use |
EP1054619B1 (en) * | 1998-02-11 | 2007-11-21 | Non-Invasive Technology, Inc. | Imaging and characterization of brain tissue |
JP4733264B2 (en) * | 1998-02-11 | 2011-07-27 | ノン−インヴェイシヴ テクノロジイ,インク. | Detection, imaging and characterization of breast tumors |
WO1999040842A1 (en) | 1998-02-13 | 1999-08-19 | Non-Invasive Technology, Inc. | Transabdominal examination, monitoring and imaging of tissue |
US20070167704A1 (en) * | 1998-02-13 | 2007-07-19 | Britton Chance | Transabdominal examination, monitoring and imaging of tissue |
US6174291B1 (en) | 1998-03-09 | 2001-01-16 | Spectrascience, Inc. | Optical biopsy system and methods for tissue diagnosis |
US7043287B1 (en) | 1998-05-18 | 2006-05-09 | Abbott Laboratories | Method for modulating light penetration depth in tissue and diagnostic applications using same |
US6662030B2 (en) | 1998-05-18 | 2003-12-09 | Abbott Laboratories | Non-invasive sensor having controllable temperature feature |
US6241663B1 (en) | 1998-05-18 | 2001-06-05 | Abbott Laboratories | Method for improving non-invasive determination of the concentration of analytes in a biological sample |
US6526298B1 (en) | 1998-05-18 | 2003-02-25 | Abbott Laboratories | Method for the non-invasive determination of analytes in a selected volume of tissue |
US6662031B1 (en) | 1998-05-18 | 2003-12-09 | Abbott Laboratoies | Method and device for the noninvasive determination of hemoglobin and hematocrit |
AU6139199A (en) * | 1998-09-11 | 2000-04-03 | Spectrx, Inc. | Multi-modal optical tissue diagnostic system |
US6157041A (en) | 1998-10-13 | 2000-12-05 | Rio Grande Medical Technologies, Inc. | Methods and apparatus for tailoring spectroscopic calibration models |
US6441388B1 (en) | 1998-10-13 | 2002-08-27 | Rio Grande Medical Technologies, Inc. | Methods and apparatus for spectroscopic calibration model transfer |
US7098037B2 (en) | 1998-10-13 | 2006-08-29 | Inlight Solutions, Inc. | Accommodating subject and instrument variations in spectroscopic determinations |
US6519486B1 (en) | 1998-10-15 | 2003-02-11 | Ntc Technology Inc. | Method, apparatus and system for removing motion artifacts from measurements of bodily parameters |
US7991448B2 (en) * | 1998-10-15 | 2011-08-02 | Philips Electronics North America Corporation | Method, apparatus, and system for removing motion artifacts from measurements of bodily parameters |
US6404497B1 (en) | 1999-01-25 | 2002-06-11 | Massachusetts Institute Of Technology | Polarized light scattering spectroscopy of tissue |
US20040147843A1 (en) * | 1999-11-05 | 2004-07-29 | Shabbir Bambot | System and method for determining tissue characteristics |
US7904139B2 (en) * | 1999-08-26 | 2011-03-08 | Non-Invasive Technology Inc. | Optical examination of biological tissue using non-contact irradiation and detection |
US7840257B2 (en) * | 2003-01-04 | 2010-11-23 | Non Invasive Technology, Inc. | Examination of biological tissue using non-contact optical probes |
US6816605B2 (en) | 1999-10-08 | 2004-11-09 | Lumidigm, Inc. | Methods and systems for biometric identification of individuals using linear optical spectroscopy |
US7006676B1 (en) | 2000-01-21 | 2006-02-28 | Medical Optical Imaging, Inc. | Method and apparatus for detecting an abnormality within a host medium utilizing frequency-swept modulation diffusion tomography |
US6577884B1 (en) | 2000-06-19 | 2003-06-10 | The General Hospital Corporation | Detection of stroke events using diffuse optical tomagraphy |
US6587703B2 (en) | 2000-09-18 | 2003-07-01 | Photonify Technologies, Inc. | System and method for measuring absolute oxygen saturation |
US6516209B2 (en) | 2000-08-04 | 2003-02-04 | Photonify Technologies, Inc. | Self-calibrating optical imaging system |
US6597931B1 (en) | 2000-09-18 | 2003-07-22 | Photonify Technologies, Inc. | System and method for absolute oxygen saturation |
US6801648B2 (en) | 2000-08-04 | 2004-10-05 | Xuefeng Cheng | Optical imaging system with symmetric optical probe |
US7043288B2 (en) | 2002-04-04 | 2006-05-09 | Inlight Solutions, Inc. | Apparatus and method for spectroscopic analysis of tissue to detect diabetes in an individual |
US7126682B2 (en) * | 2001-04-11 | 2006-10-24 | Rio Grande Medical Technologies, Inc. | Encoded variable filter spectrometer |
US6574490B2 (en) | 2001-04-11 | 2003-06-03 | Rio Grande Medical Technologies, Inc. | System for non-invasive measurement of glucose in humans |
US6983176B2 (en) | 2001-04-11 | 2006-01-03 | Rio Grande Medical Technologies, Inc. | Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopy |
US6865408B1 (en) | 2001-04-11 | 2005-03-08 | Inlight Solutions, Inc. | System for non-invasive measurement of glucose in humans |
US6862091B2 (en) | 2001-04-11 | 2005-03-01 | Inlight Solutions, Inc. | Illumination device and method for spectroscopic analysis |
US6654125B2 (en) | 2002-04-04 | 2003-11-25 | Inlight Solutions, Inc | Method and apparatus for optical spectroscopy incorporating a vertical cavity surface emitting laser (VCSEL) as an interferometer reference |
US7027848B2 (en) | 2002-04-04 | 2006-04-11 | Inlight Solutions, Inc. | Apparatus and method for non-invasive spectroscopic measurement of analytes in tissue using a matched reference analyte |
US7620212B1 (en) | 2002-08-13 | 2009-11-17 | Lumidigm, Inc. | Electro-optical sensor |
US7179279B2 (en) * | 2002-09-30 | 2007-02-20 | Medtronic Physio Control Corp. | Rapid induction of mild hypothermia |
US20040064169A1 (en) * | 2002-09-30 | 2004-04-01 | Briscoe Kathleen E. | User interface for medical device |
US7087075B2 (en) * | 2002-09-30 | 2006-08-08 | Medtronic Emergency Response Systems, Inc. | Feedback system for rapid induction of mild hypothermia |
US7056282B2 (en) * | 2002-12-23 | 2006-06-06 | Medtronic Emergency Response Systems, Inc. | Coolant control for rapid induction of mild hypothermia |
US7347365B2 (en) * | 2003-04-04 | 2008-03-25 | Lumidigm, Inc. | Combined total-internal-reflectance and tissue imaging systems and methods |
US7751594B2 (en) | 2003-04-04 | 2010-07-06 | Lumidigm, Inc. | White-light spectral biometric sensors |
KR20060002923A (en) * | 2003-04-04 | 2006-01-09 | 루미다임 인크. | Multispectral biometric sensor |
US7460696B2 (en) * | 2004-06-01 | 2008-12-02 | Lumidigm, Inc. | Multispectral imaging biometrics |
US7627151B2 (en) * | 2003-04-04 | 2009-12-01 | Lumidigm, Inc. | Systems and methods for improved biometric feature definition |
US7394919B2 (en) | 2004-06-01 | 2008-07-01 | Lumidigm, Inc. | Multispectral biometric imaging |
US7545963B2 (en) | 2003-04-04 | 2009-06-09 | Lumidigm, Inc. | Texture-biometrics sensor |
US7668350B2 (en) * | 2003-04-04 | 2010-02-23 | Lumidigm, Inc. | Comparative texture analysis of tissue for biometric spoof detection |
US7539330B2 (en) * | 2004-06-01 | 2009-05-26 | Lumidigm, Inc. | Multispectral liveness determination |
US20050007582A1 (en) * | 2003-07-07 | 2005-01-13 | Lumidigm, Inc. | Methods and apparatus for collection of optical reference measurements for monolithic sensors |
US20050027173A1 (en) * | 2003-07-31 | 2005-02-03 | Briscoe Kathleen E. | Brain injury protocols |
US20050073690A1 (en) * | 2003-10-03 | 2005-04-07 | Abbink Russell E. | Optical spectroscopy incorporating a vertical cavity surface emitting laser (VCSEL) |
US7263213B2 (en) | 2003-12-11 | 2007-08-28 | Lumidigm, Inc. | Methods and systems for estimation of personal characteristics from biometric measurements |
US8219168B2 (en) * | 2004-04-13 | 2012-07-10 | Abbott Diabetes Care Inc. | Article and method for applying a coupling agent for a non-invasive optical probe |
US7508965B2 (en) * | 2004-06-01 | 2009-03-24 | Lumidigm, Inc. | System and method for robust fingerprint acquisition |
US8229185B2 (en) * | 2004-06-01 | 2012-07-24 | Lumidigm, Inc. | Hygienic biometric sensors |
US20110163163A1 (en) * | 2004-06-01 | 2011-07-07 | Lumidigm, Inc. | Multispectral barcode imaging |
US8787630B2 (en) | 2004-08-11 | 2014-07-22 | Lumidigm, Inc. | Multispectral barcode imaging |
US7801338B2 (en) | 2005-04-27 | 2010-09-21 | Lumidigm, Inc. | Multispectral biometric sensors |
US8060189B2 (en) * | 2005-05-06 | 2011-11-15 | Infrascan, Inc. | System and method for detection of hematoma |
US7736382B2 (en) * | 2005-09-09 | 2010-06-15 | Lockheed Martin Corporation | Apparatus for optical stimulation of nerves and other animal tissue |
US8792978B2 (en) | 2010-05-28 | 2014-07-29 | Lockheed Martin Corporation | Laser-based nerve stimulators for, E.G., hearing restoration in cochlear prostheses and method |
US8956396B1 (en) | 2005-10-24 | 2015-02-17 | Lockheed Martin Corporation | Eye-tracking visual prosthetic and method |
US8709078B1 (en) | 2011-08-03 | 2014-04-29 | Lockheed Martin Corporation | Ocular implant with substantially constant retinal spacing for transmission of nerve-stimulation light |
US20080077200A1 (en) * | 2006-09-21 | 2008-03-27 | Aculight Corporation | Apparatus and method for stimulation of nerves and automated control of surgical instruments |
US8945197B1 (en) | 2005-10-24 | 2015-02-03 | Lockheed Martin Corporation | Sight-restoring visual prosthetic and method using infrared nerve-stimulation light |
US8744570B2 (en) | 2009-01-23 | 2014-06-03 | Lockheed Martin Corporation | Optical stimulation of the brainstem and/or midbrain, including auditory areas |
US8475506B1 (en) | 2007-08-13 | 2013-07-02 | Lockheed Martin Corporation | VCSEL array stimulator apparatus and method for light stimulation of bodily tissues |
US8012189B1 (en) | 2007-01-11 | 2011-09-06 | Lockheed Martin Corporation | Method and vestibular implant using optical stimulation of nerves |
US8929973B1 (en) | 2005-10-24 | 2015-01-06 | Lockheed Martin Corporation | Apparatus and method for characterizing optical sources used with human and animal tissues |
US8355545B2 (en) * | 2007-04-10 | 2013-01-15 | Lumidigm, Inc. | Biometric detection using spatial, temporal, and/or spectral techniques |
US8175346B2 (en) * | 2006-07-19 | 2012-05-08 | Lumidigm, Inc. | Whole-hand multispectral biometric imaging |
US7995808B2 (en) | 2006-07-19 | 2011-08-09 | Lumidigm, Inc. | Contactless multispectral biometric capture |
CN101506826A (en) * | 2006-07-19 | 2009-08-12 | 光谱辨识公司 | Multibiometric multispectral imager |
US7801339B2 (en) | 2006-07-31 | 2010-09-21 | Lumidigm, Inc. | Biometrics with spatiospectral spoof detection |
US7804984B2 (en) | 2006-07-31 | 2010-09-28 | Lumidigm, Inc. | Spatial-spectral fingerprint spoof detection |
US8123695B2 (en) * | 2006-09-27 | 2012-02-28 | Nellcor Puritan Bennett Llc | Method and apparatus for detection of venous pulsation |
US8160696B2 (en) | 2008-10-03 | 2012-04-17 | Lockheed Martin Corporation | Nerve stimulator and method using simultaneous electrical and optical signals |
US8996131B1 (en) | 2006-09-28 | 2015-03-31 | Lockheed Martin Corporation | Apparatus and method for managing chronic pain with infrared light sources and heat |
US8498699B2 (en) * | 2008-10-03 | 2013-07-30 | Lockheed Martin Company | Method and nerve stimulator using simultaneous electrical and optical signals |
US7883536B1 (en) | 2007-01-19 | 2011-02-08 | Lockheed Martin Corporation | Hybrid optical-electrical probes |
US8221326B2 (en) * | 2007-03-09 | 2012-07-17 | Nellcor Puritan Bennett Llc | Detection of oximetry sensor sites based on waveform characteristics |
US8229530B2 (en) * | 2007-03-09 | 2012-07-24 | Nellcor Puritan Bennett Llc | System and method for detection of venous pulsation |
US8109882B2 (en) * | 2007-03-09 | 2012-02-07 | Nellcor Puritan Bennett Llc | System and method for venous pulsation detection using near infrared wavelengths |
US8285010B2 (en) * | 2007-03-21 | 2012-10-09 | Lumidigm, Inc. | Biometrics based on locally consistent features |
US9011508B2 (en) | 2007-11-30 | 2015-04-21 | Lockheed Martin Corporation | Broad wavelength profile to homogenize the absorption profile in optical stimulation of nerves |
US8442608B2 (en) | 2007-12-28 | 2013-05-14 | Covidien Lp | System and method for estimating physiological parameters by deconvolving artifacts |
US8140272B2 (en) * | 2008-03-27 | 2012-03-20 | Nellcor Puritan Bennett Llc | System and method for unmixing spectroscopic observations with nonnegative matrix factorization |
US20100016732A1 (en) * | 2008-07-17 | 2010-01-21 | Lockheed Martin Corporation | Apparatus and method for neural-signal capture to drive neuroprostheses or control bodily function |
CN102164534B (en) * | 2008-09-26 | 2014-07-23 | 皇家飞利浦电子股份有限公司 | Detection chamber with variable volume |
US20100246902A1 (en) * | 2009-02-26 | 2010-09-30 | Lumidigm, Inc. | Method and apparatus to combine biometric sensing and other functionality |
US8872908B2 (en) * | 2009-08-26 | 2014-10-28 | Lumidigm, Inc | Dual-imager biometric sensor |
US8570149B2 (en) | 2010-03-16 | 2013-10-29 | Lumidigm, Inc. | Biometric imaging using an optical adaptive interface |
US7884933B1 (en) | 2010-05-05 | 2011-02-08 | Revolutionary Business Concepts, Inc. | Apparatus and method for determining analyte concentrations |
WO2012050847A2 (en) | 2010-09-28 | 2012-04-19 | Masimo Corporation | Depth of consciousness monitor including oximeter |
US9775545B2 (en) | 2010-09-28 | 2017-10-03 | Masimo Corporation | Magnetic electrical connector for patient monitors |
KR20140034118A (en) | 2010-11-03 | 2014-03-19 | 유니버시티 오브 워싱톤 스루 이츠 센터 포 커머셜리제이션 | Deternimation of tissue oxygenation in vivo |
BR112013016975A2 (en) * | 2011-01-04 | 2019-09-24 | Koninklijke Philips Electrnics N. V. | apparatus for optical analysis of an associated tissue, method for optical analysis of an associated tissue and computer program product |
US8870783B2 (en) | 2011-11-30 | 2014-10-28 | Covidien Lp | Pulse rate determination using Gaussian kernel smoothing of multiple inter-fiducial pulse periods |
US10154815B2 (en) | 2014-10-07 | 2018-12-18 | Masimo Corporation | Modular physiological sensors |
US9964485B2 (en) * | 2015-09-03 | 2018-05-08 | National Cheng Kung University | Optical device and method for determining an optical property of specimen |
US9554738B1 (en) * | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
US10123738B1 (en) | 2017-07-03 | 2018-11-13 | Spyros Kokolis | Methods and apparatus for skin color patient monitoring |
US10154813B1 (en) | 2017-07-03 | 2018-12-18 | Spyros Kokolis | Method and apparatus for patient skin color monitoring and drug efficacy measurement |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3229685A (en) * | 1963-04-19 | 1966-01-18 | Emerson Electric Co | Blood pressure measuring |
US3461856A (en) * | 1965-10-23 | 1969-08-19 | American Optical Corp | Oximeters |
US3638640A (en) * | 1967-11-01 | 1972-02-01 | Robert F Shaw | Oximeter and method for in vivo determination of oxygen saturation in blood using three or more different wavelengths |
CH581836A5 (en) * | 1974-08-20 | 1976-11-15 | Contraves Ag | |
JPS5725217B2 (en) * | 1974-10-14 | 1982-05-28 | ||
CA1037285A (en) * | 1975-04-30 | 1978-08-29 | Glenfield Warner | Ear oximetry process and apparatus |
US4167331A (en) * | 1976-12-20 | 1979-09-11 | Hewlett-Packard Company | Multi-wavelength incremental absorbence oximeter |
US4086652A (en) * | 1977-01-19 | 1978-04-25 | Block Engineering, Inc. | Method and apparatus for analyzing a time-dependent phenomenon |
US4281645A (en) * | 1977-06-28 | 1981-08-04 | Duke University, Inc. | Method and apparatus for monitoring metabolism in body organs |
US4714341A (en) * | 1984-02-23 | 1987-12-22 | Minolta Camera Kabushiki Kaisha | Multi-wavelength oximeter having a means for disregarding a poor signal |
CA1278044C (en) * | 1985-06-06 | 1990-12-18 | The Boc Group, Inc. | Hinged finger stall with light emitter and detector |
FR2593916B1 (en) * | 1986-01-24 | 1988-05-13 | France Etat Armement | SPECTROPHOTOMETER FOR DETERMINATION WITHIN A LIVING ORGANISM |
US4800495A (en) * | 1986-08-18 | 1989-01-24 | Physio-Control Corporation | Method and apparatus for processing signals used in oximetry |
US4824242A (en) * | 1986-09-26 | 1989-04-25 | Sensormedics Corporation | Non-invasive oximeter and method |
JPS63277039A (en) * | 1987-05-08 | 1988-11-15 | Hamamatsu Photonics Kk | Diagnostic apparatus |
US4800885A (en) * | 1987-12-02 | 1989-01-31 | The Boc Group, Inc. | Blood constituent monitoring apparatus and methods with frequency division multiplexing |
US4846183A (en) * | 1987-12-02 | 1989-07-11 | The Boc Group, Inc. | Blood parameter monitoring apparatus and methods |
US4972331A (en) * | 1989-02-06 | 1990-11-20 | Nim, Inc. | Phase modulated spectrophotometry |
US5187672A (en) * | 1989-02-06 | 1993-02-16 | Nim Incorporated | Phase modulation spectroscopic system |
US5119815A (en) * | 1988-12-21 | 1992-06-09 | Nim, Incorporated | Apparatus for determining the concentration of a tissue pigment of known absorbance, in vivo, using the decay characteristics of scintered electromagnetic radiation |
US5197470A (en) * | 1990-07-16 | 1993-03-30 | Eastman Kodak Company | Near infrared diagnostic method and instrument |
EP0591289B1 (en) * | 1991-05-16 | 1999-07-07 | Non-Invasive Technology, Inc. | Hemoglobinometers and the like for measuring the metabolic condition of a subject |
-
1993
- 1993-01-19 US US08/006,233 patent/US5402778A/en not_active Expired - Lifetime
-
1994
- 1994-01-19 CN CN94190957A patent/CN1039382C/en not_active Expired - Lifetime
- 1994-01-19 CA CA002154062A patent/CA2154062C/en not_active Expired - Lifetime
- 1994-01-19 WO PCT/US1994/000732 patent/WO1994016615A1/en active IP Right Grant
- 1994-01-19 DE DE69429426T patent/DE69429426T2/en not_active Expired - Lifetime
- 1994-01-19 EP EP94906697A patent/EP0682495B1/en not_active Expired - Lifetime
- 1994-01-19 JP JP6517186A patent/JPH08509287A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US5402778A (en) | 1995-04-04 |
DE69429426D1 (en) | 2002-01-24 |
JPH08509287A (en) | 1996-10-01 |
CN1039382C (en) | 1998-08-05 |
EP0682495A4 (en) | 1998-06-17 |
EP0682495B1 (en) | 2001-12-12 |
WO1994016615A1 (en) | 1994-08-04 |
DE69429426T2 (en) | 2002-08-08 |
CN1116819A (en) | 1996-02-14 |
EP0682495A1 (en) | 1995-11-22 |
CA2154062A1 (en) | 1994-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2154062C (en) | Spectrophotometric examination of tissue of small dimension | |
US5596987A (en) | Optical coupler for in vivo examination of biological tissue | |
EP0691820B1 (en) | Quantitative and qualitative in vivo tissue examination using time resolved spectroscopy | |
CA2494030C (en) | Method for spectrophotometric blood oxygenation monitoring | |
KR100612827B1 (en) | Method and apparatus for noninvasively measuring hemoglobin concentration and oxygen saturation | |
US5377674A (en) | Method for non-invasive and in-vitro hemoglobin concentration measurement | |
US6064474A (en) | Optical measurement of blood hematocrit incorporating a self-calibration algorithm | |
Schmitt et al. | Measurement of blood hematocrit by dual-wavelength near-IR photoplethysmography | |
EP1259791B1 (en) | Method for non-invasive spectrophotometric blood oxygenation monitoring | |
US8352005B2 (en) | Noninvasive blood analysis by optical probing of the veins under the tongue | |
US5706821A (en) | Spectroscopic method for quantitatively determining the change of concentration of a light or other radiation absorbing compound in a medium which is interrogated through an intervening medium | |
US6192260B1 (en) | Methods and apparatus for examining tissue in vivo using the decay characteristics of scattered electromagnetic radiation | |
EP0374190B1 (en) | Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment | |
De Kock et al. | Pulse oximetry: Theoretical and experimental models | |
WO1993013706A2 (en) | Optical method for monitoring arterial blood hematocrit | |
JPH0749304A (en) | Method and apparatus for measuring internal information of scattering absorbent | |
US5513642A (en) | Reflectance sensor system | |
KR20040081852A (en) | Method and apparatus for measuring concentration of constituents in body fluids | |
Matsushita et al. | Fundamental study of reflection pulse oximetry | |
Yoon et al. | Robust design of finger probe in non-invasive total haemoglobin monitor | |
Ma | A Quantitative Tissue Oximeter Using I & Q Homodyne Phase Detection System | |
CA1327899C (en) | Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light or other radiation-scattering environment | |
Hunter | Dual Wavelength Time Resolved Reflectance Measurements for the Determination of Hemoglobin Oxygenation in Tissue | |
Gravenstein et al. | Basic principles of optical radiation and some common applications in anesthesia | |
Du et al. | Quantification of NIRS data of a blood phantom by spectral multicomponent analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20140120 |